Table 4 Maternal complicationsa
Maternal complications | n = 29 |
|---|---|
VAP | 11 (37.9%) |
VAP causative pathogens | |
XDR* Acinetobacter baumannii | 1 (3.4%) |
MDR† Acinetobacter baumannii | 4 (13.8%) |
MS‡ Acinetobacter baumannii | 1 (3.4%) |
MS Staphylococcus aureus | 2 (6.9%) |
Serratia marcescens | 1 (3.4%) |
MS Klebsiella pneumoniae | 1 (3.4%) |
MS Enterobacter cloacae | 1 (3.4%) |
Acute renal failure (KDIGO)§ | 10 (34%) |
Stage 1 | 4 (13.8%) |
Stage 2 | 5 (17.2%) |
Stage 3 | 1 (3.4%) |
Renal replacement therapy | 0 (0.0%) |
Catheter-related bloodstream infection | 1 (3.4%) |
Catheter-associated urinary tract infection | 6 (20.7%) |
Pressure injury stage 2 or higher | 4 (13.8%) |
Pulmonary embolism | 1 (3.4%) |
Internal jugular and subclavian vein thrombosis | 1 (3.4%) |
Acute biliary pancreatitis | 1 (3.4%) |
COVID-19 related acute pancreatitis | 1 (3.4%) |
Upper limb bacterial cellulitis | 2 (6.9%) |
Abdominal wall infection after cesarean section | 1 (3.4%) |
Partial intestinal obstruction | 1 (3.4%) |
Postpartum hemorrhagic shock | 2 (6.9%) |